Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Atazanavir bulk supplier for pharma manufacturers

Atazanavir 150 mg, 200 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 150 mg, 200 mg, 300 mg

Reference Brands: Reyataz®(EU & US)

Category: Anti Viral

Atazanavir Capsules (150–300 mg), sold under brands like Reyataz® and Atavir®, are protease inhibitors for HIV-1 treatment. Widely used in combination therapy, they’re available for bulk procurement on PharmaB2B platforms from WHO-GMP suppliers—ideal for tenders, NGOs, and HIV programs.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Atazanavir Capsules, marketed globally under brands like Reyataz®, Atavir®, and Atazor®, are essential protease inhibitors used in combination antiretroviral therapy (cART) for HIV-1 treatment. Available in 150 mg, 200 mg, and 300 mg strengths, Atazanavir is often co-administered with Ritonavir to boost its effectiveness. With WHO and USFDA endorsements, PharmaB2B platforms enable global sourcing from GMP-certified manufacturers for bulk procurement, tenders, and public health supply chains. This once-daily dosing option is well-tolerated and vital in global HIV management programs. Partner with trusted suppliers to ensure quality and cost-effective access to key antiretroviral medicines.

Atazanavir — third party manufacturing & bulk supply

Atazanavir 150 mg, 200 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Atazanavir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Atazanavir →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Atazanavir is an antiretroviral medication used to treat HIV infection. It works by inhibiting the HIV protease enzyme, preventing the virus from maturing and multiplying, thereby helping to control viral load and improve immune function.

Atazanavir is made from a synthetic protease inhibitor compound that targets HIV protease to block viral replication.

A common trade name for Atazanavir is Reyataz.

Reyataz (Atazanavir) is manufactured by Bristol-Myers Squibb, with multiple generic versions produced by other pharmaceutical companies globally.

The generic name is atazanavir.

The brand name is Reyataz, along with other regional generic brands.

Atazanavir is manufactured in multiple regions, including India, the USA, and Europe, by licensed pharmaceutical manufacturers.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.